Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HEK293-D2089 |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | V. Mordasini et al., Oncotarget, 2017, 8 ( 4): 6461-6474 | Link | ||
HEK293-rB95.8 |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | cotransfection (plasmid/plasmid) | Metafectene | publication | J. Rac et al., PLoS ONE, 2015, 10(4): e0123645; doi:10.1371/journal.pone.0123645 | Link | ||
HEK293-rB95.8 |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | J. Rac et al., PLoS ONE, 2015, 10(4): e0123645; doi:10.1371/journal.pone.0123645 | Link | ||
HEK293N |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | Metafectene | publication | T. Bourquard et al., J. Immunol., 2018, ji1701722, DOI: https://doi.org/10.4049/jimmunol.1701722 | ||||
HEK293S |
Human embryonic kidney cell line | Human | urinary system | cell line | adherent | plasmid | Metafectene EASY | publication | C.-Y. Lin et al., PLoS ONE, 2015, 10(4): e0123562; doi:10.1371/journal.pone.0123562 | Link | |||
HEK293TN |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | F. Walter, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HEK293TN |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | plasmid | virusproduction | Metafectene | publication | L. M. Williams, Dissertation, 2014, Royal College of Surgeons in Ireland | Link | ||
HEKT Epac-S-H187 |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | A. Rodrıguez Gonzalez et al., The FEBS J., 2020, 288:229–243, doi:10.1111/febs.15344 | ||||
HEKT Epac-S-H187 |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | C. I. McCarthy et al., J. Gen. Physiol., 2020, 152, 5: e201912492, doi.org/10.1085/jgp.201912492 | Link | |||
HEKT Epac-S-H187 |
Human embryonic kidney cell line, SV40 large T antigen inserted (derivative of 293T) | Human | urinary system | cell line | adherent | plasmid | K2 Transfection System | publication | E. Echeverría et al., Front. Pharmacol., 2020, 11: 113, doi: 10.3389/fphar.2020.00113 | Link | |||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | N. Sato et al., Int. Immunol., Dec 2005; 17: 1543 - 1552 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | K2 Transfection System | application note | ![]() |
||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | P. Wolter et al., J. Cell Sci., May 2012; 125: 2393 - 2406 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene | publication | M. Mahmoodi et al., IET Nanobiotechnol., 2017, 11 (8): 995-1004 | |||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | K. J. Choi et al., Cancer Res., Apr 2007; 67: 3654 - 3662 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene PRO | publication | K. Fortschegger et al., Mol. Cancer Res., Apr 2014; 12: 595 - 606 | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C. Benincá et al., J. Med. Genet., 2021, 58: 155–167, doi:10.1136/jmedgenet-2020-106861 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | K2 Transfection System | application note | ![]() |
|||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene EASY | application note | ![]() |
|||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | Metafectene PRO | publication | M. G. Aluigi et al., Eur J Histochem, Oct 2007; 51(4): 301-4 | |||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S. Cohen et al., Biochim. et Biophysica Acta, 2013, 1833: 1104–1113, doi.org/10.1016/j.bbamcr.2012.12.021 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | oligonucleotide | DOTAP | publication | B. Anayat, Dissertation, 2021, University Konstanz | Link | ||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | RNA-Interference | Metafectene EASY | publication | M. De Luca et al., J. Cell Sci., Jun 2014; 127: 2697 - 2708 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. Fathinajafabadi et al., PLoS ONE, 2014, 9(2): e87898, doi:10.1371/journal.pone.0087898 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | K. Klement et al., J. Cell Biol., Dec 2014; 207: 717 - 733 | Link |